Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127887722> ?p ?o ?g. }
- W2127887722 endingPage "e2080" @default.
- W2127887722 startingPage "e2080" @default.
- W2127887722 abstract "Lymphatic filariasis (LF) is a debilitating vector-borne disease predominantly caused by the helminths Wuchereria bancrofti and Brugia malayi [1], [2]. Endemic in 72 countries, LF is responsible for 5.9 million DALYs lost and is implicated as the second leading cause of disability worldwide by the World Health Organization (WHO) [3]–[5]. Although 70% of those infected do not exhibit symptoms, almost all persons infected have subclinical damage to the lymphatic vessels [6], [7]. An estimated 40 million people are symptomatic with the predominant morbidities associated with LF: lymphedema and/or hydrocele [8].In recognition of the worldwide burden of LF, in 1997, the World Health Assembly passed the resolution WHA 50.29 calling for collaborative efforts by member states to eliminate the disease as a public health problem [9]. In 2000, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) was formed in response to the WHA resolution and aimed to eliminate the disease by 2020. The program adopted a two-pronged strategy: (1) to interrupt transmission of the causal parasite and (2) to alleviate morbidities associated with the disease [10]. The two pillars of the GPELF's strategy form the basic framework for any successful LF program.Togo is one of the 34 African countries endemic for lymphatic filariasis and is surrounded by the endemic countries of Benin, Ghana, and Burkina Faso [11]. The National Program to Eliminate Lymphatic Filariasis (NPELF) was founded in 2000 and is one of the few LF programs that address the dual goals of the global elimination program on a national scale. Togo is the first sub-Saharan country to achieve probable interruption of transmission and to move to the post-MDA surveillance phase as defined by the WHO [12]. Here we describe the elements that proved successful in the national strategy to address LF in Togo." @default.
- W2127887722 created "2016-06-24" @default.
- W2127887722 creator A5008264373 @default.
- W2127887722 creator A5016204714 @default.
- W2127887722 creator A5021159799 @default.
- W2127887722 creator A5057071125 @default.
- W2127887722 creator A5075448710 @default.
- W2127887722 creator A5080260476 @default.
- W2127887722 creator A5084826056 @default.
- W2127887722 creator A5088593356 @default.
- W2127887722 creator A5090268183 @default.
- W2127887722 date "2013-04-11" @default.
- W2127887722 modified "2023-10-11" @default.
- W2127887722 title "A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation" @default.
- W2127887722 cites W1494041818 @default.
- W2127887722 cites W1966600455 @default.
- W2127887722 cites W1986532204 @default.
- W2127887722 cites W1990160605 @default.
- W2127887722 cites W1990721074 @default.
- W2127887722 cites W2000402496 @default.
- W2127887722 cites W2014082530 @default.
- W2127887722 cites W2031335065 @default.
- W2127887722 cites W2032880964 @default.
- W2127887722 cites W2038319189 @default.
- W2127887722 cites W2069747930 @default.
- W2127887722 cites W2104239932 @default.
- W2127887722 cites W2105654937 @default.
- W2127887722 cites W2146139459 @default.
- W2127887722 cites W2146849606 @default.
- W2127887722 cites W2168554027 @default.
- W2127887722 cites W2801039291 @default.
- W2127887722 cites W3142484947 @default.
- W2127887722 doi "https://doi.org/10.1371/journal.pntd.0002080" @default.
- W2127887722 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3623714" @default.
- W2127887722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23593512" @default.
- W2127887722 hasPublicationYear "2013" @default.
- W2127887722 type Work @default.
- W2127887722 sameAs 2127887722 @default.
- W2127887722 citedByCount "49" @default.
- W2127887722 countsByYear W21278877222013 @default.
- W2127887722 countsByYear W21278877222014 @default.
- W2127887722 countsByYear W21278877222015 @default.
- W2127887722 countsByYear W21278877222016 @default.
- W2127887722 countsByYear W21278877222017 @default.
- W2127887722 countsByYear W21278877222018 @default.
- W2127887722 countsByYear W21278877222019 @default.
- W2127887722 countsByYear W21278877222020 @default.
- W2127887722 countsByYear W21278877222021 @default.
- W2127887722 countsByYear W21278877222022 @default.
- W2127887722 countsByYear W21278877222023 @default.
- W2127887722 crossrefType "journal-article" @default.
- W2127887722 hasAuthorship W2127887722A5008264373 @default.
- W2127887722 hasAuthorship W2127887722A5016204714 @default.
- W2127887722 hasAuthorship W2127887722A5021159799 @default.
- W2127887722 hasAuthorship W2127887722A5057071125 @default.
- W2127887722 hasAuthorship W2127887722A5075448710 @default.
- W2127887722 hasAuthorship W2127887722A5080260476 @default.
- W2127887722 hasAuthorship W2127887722A5084826056 @default.
- W2127887722 hasAuthorship W2127887722A5088593356 @default.
- W2127887722 hasAuthorship W2127887722A5090268183 @default.
- W2127887722 hasBestOaLocation W21278877221 @default.
- W2127887722 hasConcept C138816342 @default.
- W2127887722 hasConcept C142724271 @default.
- W2127887722 hasConcept C165901193 @default.
- W2127887722 hasConcept C17744445 @default.
- W2127887722 hasConcept C199539241 @default.
- W2127887722 hasConcept C203014093 @default.
- W2127887722 hasConcept C205649164 @default.
- W2127887722 hasConcept C2776158911 @default.
- W2127887722 hasConcept C2776246342 @default.
- W2127887722 hasConcept C2777629521 @default.
- W2127887722 hasConcept C2780133432 @default.
- W2127887722 hasConcept C2780303919 @default.
- W2127887722 hasConcept C2780765947 @default.
- W2127887722 hasConcept C2908647359 @default.
- W2127887722 hasConcept C556039675 @default.
- W2127887722 hasConcept C71924100 @default.
- W2127887722 hasConcept C99454951 @default.
- W2127887722 hasConceptScore W2127887722C138816342 @default.
- W2127887722 hasConceptScore W2127887722C142724271 @default.
- W2127887722 hasConceptScore W2127887722C165901193 @default.
- W2127887722 hasConceptScore W2127887722C17744445 @default.
- W2127887722 hasConceptScore W2127887722C199539241 @default.
- W2127887722 hasConceptScore W2127887722C203014093 @default.
- W2127887722 hasConceptScore W2127887722C205649164 @default.
- W2127887722 hasConceptScore W2127887722C2776158911 @default.
- W2127887722 hasConceptScore W2127887722C2776246342 @default.
- W2127887722 hasConceptScore W2127887722C2777629521 @default.
- W2127887722 hasConceptScore W2127887722C2780133432 @default.
- W2127887722 hasConceptScore W2127887722C2780303919 @default.
- W2127887722 hasConceptScore W2127887722C2780765947 @default.
- W2127887722 hasConceptScore W2127887722C2908647359 @default.
- W2127887722 hasConceptScore W2127887722C556039675 @default.
- W2127887722 hasConceptScore W2127887722C71924100 @default.
- W2127887722 hasConceptScore W2127887722C99454951 @default.
- W2127887722 hasIssue "4" @default.
- W2127887722 hasLocation W21278877221 @default.
- W2127887722 hasLocation W21278877222 @default.